Sections

Better than Viagra! Sale of Pfizer plant gives rise to job hopes

The Brooklyn Paper
Share on TwitterTweet
Share on Facebook
Subscribe

Don’t miss our updates:

For Brooklyn’s unemployed factory workers — this pill is easy to swallow.

Global pharmaceutical giant Pfizer sold its defunct Flushing Avenue manufacturing plant this week to Acumen Capital Partners, a Queens-based development company that says it will turn the site into a hub of working industry.

Pfizer spokesman Christopher Loder called the sale a “very positive step forward” toward bringing jobs to Williamsburg — but the deal does not include several Pfizer-owned vacant lots that have long been discussed for housing development.

For that reason, Assemblyman Vito Lopez (D–Williamsbu­rg) said he was “very disappointed” — and told the New York Post that he would renew his bid to seize several Pfizer-owned lots through eminent domain.

But on Monday, Brooklyn’s business leaders hailed the sale of at least part of the site.

“In order to stay competitive, America must return to the days when its industrial base was the envy of the world,” said Borough President Markowitz. “On this Valentine’s Day, Cupid’s arrow — and Acumen’s acumen — are bringing a wellspring of opportunity to the beating heart of Brooklyn.”

The deal ends a frustrating three-year campaign by executives at the Viagra manufacturer to redevelop the site where its corporate headquarters was founded in 1849.

The company manufactured prescription drugs at the site since 1946, but shut down its factory for good in 2007, eliminating 600 jobs.

Pfizer put the plant and its surrounding property on the market — but could not close a deal as the commercial real-estate market floundered and New York’s manufacturing base continued to erode.

Details surrounding the sale remain unclear, but Acumen is known for buying vacant commercial buildings in Queens and transforming them into light manufacturing centers.

In 2008, Acumen bought Long Island City’s Standard Motor Products Building, a building half the size of the 660,000-square-foot Pfizer facility, for $40.6 million. That factory is now home to the Jim Henson Company and a rooftop garden, ironically called “Brooklyn Grange.”

Calls made to Acumen were not returned by press time.

Updated 12:12 am, February 15, 2011
Today’s news:
Share on TwitterTweet
Share on Facebook
Subscribe

Don’t miss our updates:

Reasonable discourse

Joey from Clinton Hills says:
how about a large lazer tag park?
Feb. 15, 2011, 10:32 am

Enter your comment below

By submitting this comment, you agree to the following terms:

You agree that you, and not BrooklynPaper.com or its affiliates, are fully responsible for the content that you post. You agree not to post any abusive, obscene, vulgar, slanderous, hateful, threatening or sexually-oriented material or any material that may violate applicable law; doing so may lead to the removal of your post and to your being permanently banned from posting to the site. You grant to BrooklynPaper.com the royalty-free, irrevocable, perpetual and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part world-wide and to incorporate it in other works in any form, media or technology now known or later developed.

First name
Last name
Your neighborhood
Email address
Daytime phone

Your letter must be signed and include all of the information requested above. (Only your name and neighborhood are published with the letter.) Letters should be as brief as possible; while they may discuss any topic of interest to our readers, priority will be given to letters that relate to stories covered by The Brooklyn Paper.

Letters will be edited at the sole discretion of the editor, may be published in whole or part in any media, and upon publication become the property of The Brooklyn Paper. The earlier in the week you send your letter, the better.

Don’t miss out!

Stay in touch with the stories people are talking about in your neighborhood:

Optional: Help us tailor our newsletters to you!